Metabolix Now Shipping I6001 PHA-based Polymeric Modifier for PVC
New Polymeric Modifier Provides Significant Impact Resistance in
Rigid and Flexible PVC Formulations
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Inc. (NASDAQ: MBLX), an innovation-driven bioscience company focused on
delivering sustainable solutions for plastics, chemicals and energy,
today announced that I6001, a biobased polymeric modifier for PVC
(polyvinyl chloride) formulations based on Metabolix PHA resin, is now
available for shipment to customers. Metabolix designed I6001 as a
performance additive to improve the mechanical and environmental
performance characteristics of PVC. With a diverse use pattern ranging
from construction materials to medical applications, PVC has an
estimated market demand of approximately 35 million metric tons per year.
Metabolix researchers recently developed a series of PHA-based polymeric
modifiers and presented data demonstrating very good miscibility with
PVC and significant improvements in the modification and processing of
PVC. Based on these findings, Metabolix developed I6001 polymeric
modifier which significantly improves impact resistance and toughness in
rigid and flexible PVC applications without compromising PVC
transparency or UV stability. I6001 also may serve as a PVC processing
aid due to its excellent miscibility and shear melting with PVC.
Additional benefits of I6001 include plasticization, low modifier
volatization and low extractables. I6001 is 85 percent biobased and is
now available commercially.
Metabolix is developing a series of second generation products in the
modifier space which the Company plans to launch in 2013 in conjunction
with the planned start-up of PHA biopolymer manufacturing in Spain.
"As our new polymeric modifier for PVC, I6001 contributes renewable
content while delivering an impressive set of processing advantages and
performance characteristics," said Bob Engle, vice president, commercial
development of biopolymers at Metabolix. "We look forward to working
with customers to identify suitable applications for PVC formulations
using our polymeric modifiers. Next year, we are planning to introduce
additional performance additives with very high biocontent for PVC and
other commercially important resins to underscore our commitment to
providing customers with sustainable, high-performance products that
enable them to satisfy consumer demands, differentiate brands and meet
evolving government regulations."
Product information on I6001 including a data sheet and processing guide
can be found on www.metabolix.com.
Metabolix, Inc. is an innovation-driven bioscience company delivering
sustainable solutions to the plastics, chemicals and energy industries.
Metabolix is developing and commercializing a family of high-performance
biopolymers targeted to the markets for film and bag applications,
performance additives and functional biodegradation. Metabolix's
biobased chemicals platform utilizes its novel "FAST" recovery process
to enable the production of cost-effective, "drop-in" replacements for
petroleum-based industrial chemicals. The Company is also developing a
platform for co-producing plastics, chemicals and energy from crops.
Metabolix has established an industry-leading intellectual property
portfolio that, together with its knowledge of advanced industrial
practice, provides a foundation for industry collaborations.
For more information, please visit www.metabolix.com.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made
pursuant to the safe harbor provisions of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. The forward-looking statements in this release do
not constitute guarantees of future performance. Investors are cautioned
that statements in this press release which are not strictly historical
statements, including, without limitation, statements regarding the
ability to develop, manufacture, and market PHA as polymeric PVC
modifiers and performance additives, constitute forward-looking
statements. Such forward-looking statements are subject to a number of
risks and uncertainties that could cause actual results to differ
materially from those anticipated and are detailed in Metabolix's
filings with the Securities and Exchange Commission. Metabolix assumes
no obligation to update any forward-looking information contained in
this press release or with respect to the announcements described herein.
Media and General Inquiries:
Keith Giannini or Kirsten Swenson, 781-684-0770
Source: Metabolix, Inc.
News Provided by Acquire Media
Close window | Back to top